Patents Assigned to BIONURE FARMA, S.L.
  • Agonists of neurotrophin receptors and their use as medicaments
    Patent number: 10106577
    Abstract: The invention relates to compounds of Formula I: and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, and R3 are defined as set forth in the specification. The compounds are agonists of neurotrophin (such as nerve growth factor) receptors.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: October 23, 2018
    Assignees: BIONURE FARMA, S.L., INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (IDIBAPS), CONSEJO SUPERIOR DE INVESTIGACIONS CIENTIFICAS (CSIC)
    Inventors: Pablo Villoslada, Angel Messeguer
  • AGONISTS OF NEUROTROPHIN RECEPTORS AND THEIR USE AS MEDICAMENTS
    Publication number: 20170121367
    Abstract: The invention relates to compounds of Formula I: and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, and R3 are defined as set forth in the specification. The compounds are agonists of neurotrophin (such as nerve growth factor) receptors.
    Type: Application
    Filed: September 9, 2016
    Publication date: May 4, 2017
    Applicants: BIONURE FARMA, S.L. (undivided 50% interest), INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (IDIBAPS) (undivided 30% interest), CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (undivided 20% interest)
    Inventors: Pablo VILLOSLADA, Angel MESSEGUER
  • Agonists of neurotrophin receptors and their use as medicaments
    Patent number: 9453047
    Abstract: The invention relates to compounds of Formula I: and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, and R3 are defined as set forth in the specification. The compounds are agonists of neurotrophin (such as nerve growth factor) receptors.
    Type: Grant
    Filed: June 11, 2014
    Date of Patent: September 27, 2016
    Assignees: BIONURE FARMA, S.L., INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PII SUNYER (IDIBAPS) (undivided 30% interest), CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (individed 20% interest)
    Inventors: Pablo Villoslada, Angel Messeguer